Skip to main content
Inebilizumab ‘MITIGATES’ Flare Risk in IgG4-Related Disease
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Inebilizumab ‘MITIGATES’ Flare Risk in IgG4-Related Disease
User login
Username
Password
Reset your password
Specialty
Lead
score
Rheumatology
1
1
Internal Medicine
0
0.9
Pharmacist
0
0.8
Concept
Lead
score
Biologic Therapy
1
1
Immunoglobulin G4 Related Disease
0
0.99
Glucocorticoid
0
0.26
Remission
0
0.19
Arthralgia
0
0.1
Corticosteroids
0
0.1
Hospital
0
0.1
Immunoglobulin A (IgA)
0
0.1
Intravenous
0
0.1
Massachusetts
0
0.1
Monoclonal Antibody
0
0.1
Neuromyelitis Optica
0
0.1
Urinary Tract Infection
0
0.1
Edit Tags